Sec 6-59 Amended — File 24-0144

Guidelines shall mean: a) NIH Guidelines: National Institutes of Health (“NIH”) Guidelines for Research Involving Recombinant DNA Molecules as published in the Federal Register of May 7, 1986, as well as NIH’s Design Requirements Manual as amended, March 5, 2020 for proposed BSL-3 laboratories, and b) BMBL: Biosafety in Microbiological and Biomedical Laboratories as published by the Centers for Disease Control and Prevention (“CDC”) and National Institutes of Health, as amended, and c) Any amendments, revisions, new editions, or substitutions to the NIH Guidelines or the BMBL, which are adopted by the US Department of Health and Human Services, CDC, and NIH (or a successor agency) that are accepted by the SBC. Any such amendments, revisions, new editions, or substitutions not acted upon by the SBC within sixty (60) days of their effective date shall be considered accepted. In the event that NIH Guidelines or BMBL are discontinued or abolished, those guidelines in effect at the time of such discontinuance shall remain in effect for purposes of this article. In the event that there is a conflict between the NIH Guidelines and the BMBL, the Committee shall require the more restrictive of the two.